The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Elevance Health Inc. (ELV) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.09, or -0.02%, to $477.78. The Elevance Health Inc. has recorded 26,413 volume in the after hours trading session. Most recently, Yahoo Finance reported about the stock as it publicized that Elevance Health’s 2.750% Senior Convertible Debentures due 2042 to Accrue Contingent Interest.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
The company is listed on the NYSE and operates within the Healthcare Plans industry segment. At the end of the last regular session, the stock closed at $477.87 and fluctuated between $478.03 as its day high and $470.28 as its day low. The current market capitalization of Elevance Health Inc. is $114.77B. A total of 1.01 million shares were traded on the day, compared to an average of 1.17M shares.
Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, ELV has seen 1 BUY and 2 SELL insider trades, representing the acquisition of 3,983 and the disposition of 1,871 shares. Over the last 12 months, there were 34 BUYs and 35 SELLs from insiders. Insiders purchased 102,686 shares during that period but sold 79,064.
The dividend paying company demonstrates a positive outlook for investors and helps them generate immediate cash. Elevance Health Inc. pays an annual dividend of $5.92, resulting in a dividend yield of 1.24%, and it has a price to earnings (P/E) ratio of 19.28. ELV’s most recent ex-dividend date was 3/9/2023 when it declared a $1.48 quarterly dividend that was paid in cash on 3/24/2023. Previously, the company paid the dividend on 12/21/2022 with an ex-dividend date of 12/2/2022. The ELV stock dividend was $1.28 per share in cash.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for ELV in the last 3 months, the mean price target is $585.17 with high estimates of $620.00 and low estimates of $523.00. In terms of 52-week highs and lows, ELV has a high of $549.52 and a low of $432.03.
As of this writing, ELV has an earnings estimate of $5.2 per share for the current quarter. EPS was calculated based on a consensus of 19 estimates, with a high estimate of $5.32 per share and a lower estimate of $5.12. The company reported an EPS of $8.04 in the last quarter, which was 3.90% higher than expectations of $7.74.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information.
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 20 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ELV is Sell with a score of 4.71. A total of 14 analysts rated the stock as Buy while 2 rated it as Overweight while 4 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.